XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2020
Summary of Product Revenue

Our product revenue, net consisted of the following:

 

 

Year Ended

 

 

 

December 31

 

 

 

2020

 

 

2019

 

 

2018

 

HEPLISAV-B

 

$

36,030

 

 

$

34,644

 

 

$

6,812

 

CpG 1018

 

 

3,277

 

 

 

-

 

 

 

-

 

Total

 

$

39,307

 

 

$

34,644

 

 

$

6,812

 
HEPLISAV-B  
Summary of Product Revenue Allowance and Reserve Categories The following table summarizes balances and activities in HEPLISAV-B product revenue allowance and reserve categories for the year ended December 31, 2020 and 2019 (in thousands):

 

 

Balance at

Beginning of

Period

 

 

Provisions

related to current

period sales

 

 

Credit or payments

made during

the period

 

 

Balance

at End of

Period

 

Year ended December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable reserves(1)

 

$

2,701

 

 

$

11,417

 

 

$

(11,282

)

 

$

2,836

 

Revenue reserve accruals(2)

 

$

3,893

 

 

$

6,694

 

 

$

(4,547

)

 

$

6,040

 

Year ended December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable reserves(1)

 

$

1,272

 

 

$

11,042

 

 

$

(9,613

)

 

$

2,701

 

Revenue reserve accruals(2)

 

$

1,033

 

 

$

6,632

 

 

$

(3,772

)

 

$

3,893

 

 

(1)

Reserves are for chargebacks, discounts and other fees.

(2)

Accruals are for returns, rebates and other fees